DAWN Executive Compensation
* In USD (Original Currency)|
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
|---|---|---|---|---|---|---|---|---|
| 2024-04-05 | 2021 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,840 |
| 2024-04-05 | 2023 | Jeremy Bender Chief Executive Officer and President | 647,000 | 0 | 1,779,160 | 388,200 | 13,200 | 6,913,959 |
| 2024-04-05 | 2022 | Jeremy Bender Chief Executive Officer and President | 610,000 | 0 | 812,820 | 290,000 | 12,200 | 5,086,456 |
| 2024-04-05 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,110 |
| 2024-04-05 | 2023 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 515,000 | 0 | 842,760 | 231,800 | 13,200 | 3,546,093 |
| 2024-04-05 | 2022 | Charles N. York II Chief Operating Officer, Chief Financial Officer and Secretary | 495,000 | 0 | 313,720 | 220,000 | 12,200 | 2,319,451 |
| 2024-04-05 | 2021 | Samuel Blackman Co-Founder and Head of Research and Development | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,890 |
| 2024-04-05 | 2022 | Samuel Blackman Co-Founder and Head of Research and Development | 470,000 | 0 | 270,940 | 181,000 | 12,200 | 2,077,197 |
| 2024-04-05 | 2023 | Samuel Blackman Co-Founder and Head of Research and Development | 500,000 | 0 | 538,430 | 227,300 | 13,200 | 2,485,392 |
| 2024-04-05 | 2023 | Adam Dubow General Counsel and Chief Compliance Officer | 425,000 | 0 | 655,480 | 170,000 | 13,200 | 2,773,253 |
| 2023-04-28 | 2021 | Samuel Blackman Co-Founder and Chief Medical Officer | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,890 |
| 2023-04-28 | 2022 | Jeremy Bender Chief Executive Officer and President | 610,000 | 0 | 812,820 | 290,000 | 0 | 5,074,256 |
| 2023-04-28 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,110 |
| 2023-04-28 | 2022 | Charles York II Chief Operating Officer and Chief Financial Officer | 495,000 | 0 | 313,720 | 220,000 | 0 | 2,307,251 |
| 2023-04-28 | 2021 | Charles York II Chief Operating Officer and Chief Financial Officer | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,840 |
| 2023-04-28 | 2022 | Samuel Blackman Co-Founder and Chief Medical Officer | 470,000 | 0 | 270,940 | 181,000 | 0 | 2,064,997 |
| 2022-04-28 | 2021 | Jeremy Bender Chief Executive Officer and President | 523,021 | 0 | 5,168,061 | 313,800 | 0 | 19,761,109 |
| 2022-04-28 | 2020 | Samuel Blackman Co-Founder and Chief Medical Officer | 367,000 | 0 | 0 | 110,100 | 0 | 477,100 |
| 2022-04-28 | 2021 | Samuel Blackman Co-Founder and Chief Medical Officer | 422,568 | 0 | 493,000 | 205,000 | 0 | 2,935,891 |
| 2022-04-28 | 2021 | Charles York II Chief Operating Officer and Chief Financial Officer | 396,042 | 100,000 | 2,534,266 | 218,300 | 0 | 7,918,839 |
| 2022-04-28 | 2020 | Jeremy Bender Chief Executive Officer and President | 141,667 | 0 | 2,555,158 | 56,356 | 0 | 2,753,181 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
